Next report date
Report period
Q2 2024
EPS estimate
0.03EUR
Revenue estimate
398.21 MEUR
0.11EUR
205.22 MEUR
1.48 BEUR
286.09 M
About PHARMARON BEIJING
Sector
CEO
Bo Liang Lou
Website
Headquarters
Beijing
Employees (FY)
20.3 K
Founded
2004
ISIN
CNE100003PG4
FIGI
BBG00R83LKL4
Pharmaron Beijing Co., Ltd. engages in the provision of full-process integrated drug research, development, and production services from drug discovery to drug development. It provides laboratory, CMC, macromolecules and cell & gene therapy, and clinical research services. The company was founded by Bo Liang Lou, Xiao Qiang Lou and Bei Zheng on July 1, 2004 and is headquartered in Beijing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PHARMARON BEIJING H YC1 stocks are traded under the ticker 17Q1.
PHARMARON BEIJING H YC1 is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
17Q1 earnings for the last quarter are 0.03 EUR per share, whereas the estimation was 0.03 EUR resulting in a −1.91% surprise. The estimated earnings for the next quarter are 0.03 EUR per share. See more details about PHARMARON BEIJING H YC1 earnings.
PHARMARON BEIJING H YC1 revenue for the last quarter amounts to 374.07 M EUR despite the estimated figure of 386.35 M EUR. In the next quarter revenue is expected to reach 371.65 M EUR.
Yes, you can track PHARMARON BEIJING H YC1 financials in yearly and quarterly reports right on TradingView.
17Q1 net income for the last quarter is 29.70 M EUR, while the quarter before that showed 57.94 M EUR of net income which accounts for −48.74% change. Track more PHARMARON BEIJING H YC1 financial stats to get the full picture.
Yes, 17Q1 dividends are paid annually. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (TTM)% is 2.09%. Tracking PHARMARON BEIJING H YC1 dividends might help you take more informed decisions.
PHARMARON BEIJING H YC1 dividend yield was 1.36% in 2023, and payout ratio reached 21.63%. The year before the numbers were 0.61% and 24.31% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 17Q1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMARON BEIJING H YC1 stock right from TradingView charts — choose your broker and connect to your account.
17Q1 reached its all-time high on Jun 28, 2021 with the price of 10.13 EUR, and its all-time low was 0.000444 EUR and was reached on Jul 17, 2007. View more price dynamics on 17Q1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 3, 2024, the company has 20.30 K employees. See our rating of the largest employees — is PHARMARON BEIJING H YC1 on this list?
We've gathered analysts' opinions on PHARMARON BEIJING H YC1 future price: according to them, 17Q1 price has a max estimate of 3.58 EUR and a min estimate of 0.96 EUR. Watch 17Q1 chart and read a more detailed PHARMARON BEIJING H YC1 stock forecast: see what analysts think of PHARMARON BEIJING H YC1 and suggest that you do with its stocks.